PHARMA INDUSTRY PUSHES FORWARD ON USING INTERACTIVE TECHNOLOGY IN CLINICAL TRIALS
March 1st, 2014
The European Medicines Agency (EMA) has assessed several hundred responses from the pharmaceutical industry to a “reflection paper on the use of interactive response technologies (interactive voice/web response systems or IRT) in clinical trials.” An EMA official explained to Manufacturing Chemist that the intention of the paper and the consultation was “to provide the current thinking of the inspectors working groups on the use of interactive response technology systems, with particular mention of the removal of expiry dates from investigational medicinal ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.